1. Home
  2. NCSM vs LEXX Comparison

NCSM vs LEXX Comparison

Compare NCSM & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCS Multistage Holdings Inc.

NCSM

NCS Multistage Holdings Inc.

HOLD

Current Price

$42.46

Market Cap

97.3M

Sector

Energy

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.90

Market Cap

22.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCSM
LEXX
Founded
2006
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.3M
22.7M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
NCSM
LEXX
Price
$42.46
$0.90
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
15.0K
167.8K
Earning Date
10-29-2025
01-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.53
N/A
Revenue
$178,000,000.00
$705,923.00
Revenue This Year
$11.25
$13.35
Revenue Next Year
$7.76
$78.83
P/E Ratio
$9.39
N/A
Revenue Growth
16.49
52.05
52 Week Low
$23.03
$0.77
52 Week High
$53.69
$2.43

Technical Indicators

Market Signals
Indicator
NCSM
LEXX
Relative Strength Index (RSI) 63.91 39.65
Support Level $40.56 $1.05
Resistance Level $45.87 $1.44
Average True Range (ATR) 2.03 0.10
MACD 0.73 -0.00
Stochastic Oscillator 71.08 12.62

Price Performance

Historical Comparison
NCSM
LEXX

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: